| Application no. and date | 01939751.2 (espacenet) (Federated) (European Patent Register), 20010531 | | Patent/reg. no. and date | DK/EP 1229909, 20031112 | | Publication date | 20020814 | | Priority no. and date | US 208789 P, 20000601 | | EP pub. no. and date |
EP 1229909 20020814 | | Effective date | | | Applicant/owner | Watson Pharmaceuticals, Inc., 311 Bonnie Circle
Corona, CA 92880, US | | Applicant ref. no. | 108495 | | Inventor | FIKSTAD, David, 726 South Green Street
Salt Lake City, UT 84102, US,
QUAN, Danyi, 4156 South Meagan Circle
Salt Lake City, UT 84107, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 9/00, A61K 9/70, A61P 5/30, A61K 31/40 | | Title | Transdermal indgivelse af lasofoxifen | | Int. application no. | US2001017567 | | Int. publication no. | WO2001091724 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
